BEVACIZUMAB — Class II drug recall D-0051-2025
Terminated recall by Tailstorm Health INC, reported 2024-11-27, distributed nationwide. Lack of Sterility Assurance
| Recall number | D-0051-2025 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Tailstorm Health INC, Phoenix, AZ, United States |
| Recall initiated | 2024-11-06 |
| Classified | 2024-11-18 |
| Reported by FDA | 2024-11-27 |
| Terminated | 2025-03-28 |
| Distributed | Nationwide (US) |
| Quantity | 27,560 syringes |
| Reason classes | sterility |
| NDC | 81483-0041-01 |
| Lot numbers | D24005, D24006, D24007, D24008, D24009, D24012 |
| Expiration dates | 2025-02-20, 2025-02-21, 2025-02-22, 2025-03-19, 2025-03-20, 2025-04-25 |
Product
BEVACIZUMAB (AVASTIN)1.25mg/0.05mL, Sterile Injection, 0.5 mL Single-Dose Syringe, Rx Only, Repackaged by: Medivant Healthcare: 24416 N 19th Ave, Phoenix, AZ, NDC 81483-0041-1
Reason for recall
Lack of Sterility Assurance
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0051-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.